Medlive - A PlatformQ Health Brand
@medliveofficial.bsky.social
Education for healthcare providers, patients & caregivers. 🩺💜👩🏻⚕️👨🏽⚕️
Make informed health decisions based on the latest science.
Access Medlive here ➡️ https://bit.ly/3QAXfVt
Make informed health decisions based on the latest science.
Access Medlive here ➡️ https://bit.ly/3QAXfVt
Reposted by Medlive - A PlatformQ Health Brand
AACI has partnered with @medliveofficial.bsky.social to share on-demand education on CAR T-cell therapy for non-Hodgkin lymphoma and multiple myeloma. Expert-led sessions cover referral pathways and management strategies for community practice.
Watch now: bit.ly/45eV1lV
Watch now: bit.ly/45eV1lV
January 30, 2026 at 3:11 PM
AACI has partnered with @medliveofficial.bsky.social to share on-demand education on CAR T-cell therapy for non-Hodgkin lymphoma and multiple myeloma. Expert-led sessions cover referral pathways and management strategies for community practice.
Watch now: bit.ly/45eV1lV
Watch now: bit.ly/45eV1lV
Welcome, Dr. Hans Lee, MD, to the Advisory Board! As Director of Myeloma Research at SCRI, he leads innovative work advancing new therapeutic strategies through early-phase clinical trials. 🩺
His insight will help strengthen our #PatientCentered, video-first oncology education. 🔗 bit.ly/4rpCI6R
His insight will help strengthen our #PatientCentered, video-first oncology education. 🔗 bit.ly/4rpCI6R
January 30, 2026 at 8:57 PM
Welcome, Dr. Hans Lee, MD, to the Advisory Board! As Director of Myeloma Research at SCRI, he leads innovative work advancing new therapeutic strategies through early-phase clinical trials. 🩺
His insight will help strengthen our #PatientCentered, video-first oncology education. 🔗 bit.ly/4rpCI6R
His insight will help strengthen our #PatientCentered, video-first oncology education. 🔗 bit.ly/4rpCI6R
Are you up to date on care for Multifocal Motor Neuropathy (MMN)?
Join us live today at 2:00 PM ET for expert insights on diagnosis and emerging treatment options.
👉 Save your spot now: bit.ly/4c0ePy9
#MMN #Neurology #CME #MedicalEducation #ClinicalPractice
Join us live today at 2:00 PM ET for expert insights on diagnosis and emerging treatment options.
👉 Save your spot now: bit.ly/4c0ePy9
#MMN #Neurology #CME #MedicalEducation #ClinicalPractice
January 30, 2026 at 3:00 PM
Are you up to date on care for Multifocal Motor Neuropathy (MMN)?
Join us live today at 2:00 PM ET for expert insights on diagnosis and emerging treatment options.
👉 Save your spot now: bit.ly/4c0ePy9
#MMN #Neurology #CME #MedicalEducation #ClinicalPractice
Join us live today at 2:00 PM ET for expert insights on diagnosis and emerging treatment options.
👉 Save your spot now: bit.ly/4c0ePy9
#MMN #Neurology #CME #MedicalEducation #ClinicalPractice
Honored to welcome Dr. Ghassan Abou-Alfa, MD, JD, MBA, PhD(hc) to the Advisory Board. As a Professor of Medicine & an Attending Physician at @mskcancercenter.bsky.social, he brings deep expertise in hepatobiliary cancers to our #PatientCentered digital education. 👏💡
Read more 🔗 bit.ly/4q9GPD4
Read more 🔗 bit.ly/4q9GPD4
January 28, 2026 at 10:31 PM
Honored to welcome Dr. Ghassan Abou-Alfa, MD, JD, MBA, PhD(hc) to the Advisory Board. As a Professor of Medicine & an Attending Physician at @mskcancercenter.bsky.social, he brings deep expertise in hepatobiliary cancers to our #PatientCentered digital education. 👏💡
Read more 🔗 bit.ly/4q9GPD4
Read more 🔗 bit.ly/4q9GPD4
New on-demand #CME explores type 2 inflammation and eosinophils in COPD, with practical guidance on personalizing care and emerging biologics.
Watch on demand 👉 bit.ly/4q5xTyx
#MedicalEducation #Pulmonology #COPD #EosinophilicCOPD #Type2Inflammation
Watch on demand 👉 bit.ly/4q5xTyx
#MedicalEducation #Pulmonology #COPD #EosinophilicCOPD #Type2Inflammation
January 28, 2026 at 9:00 PM
New on-demand #CME explores type 2 inflammation and eosinophils in COPD, with practical guidance on personalizing care and emerging biologics.
Watch on demand 👉 bit.ly/4q5xTyx
#MedicalEducation #Pulmonology #COPD #EosinophilicCOPD #Type2Inflammation
Watch on demand 👉 bit.ly/4q5xTyx
#MedicalEducation #Pulmonology #COPD #EosinophilicCOPD #Type2Inflammation
Welcome Dr. Aaron Lisberg, MD, Assistant Professor of Clinical Medicine at UCLA, to the Medlive Advisory Board. 👏 A leader in #immunotherapy + thoracic #oncology, he’s partnered with us since 2020 to advance clinician + patient education in #CancerCare. Read more: bit.ly/3M7wf1l
January 26, 2026 at 3:09 PM
Welcome Dr. Aaron Lisberg, MD, Assistant Professor of Clinical Medicine at UCLA, to the Medlive Advisory Board. 👏 A leader in #immunotherapy + thoracic #oncology, he’s partnered with us since 2020 to advance clinician + patient education in #CancerCare. Read more: bit.ly/3M7wf1l
We're heading to #Alliance26 to present outcomes from our patient-centered video-first education shaped by partners like @aafanational.bsky.social
Excited to join @alliance4cehp.bsky.social in celebrating 50 yrs of advancing continuing education, alongside fellow #CME leaders 🔗 bit.ly/45XLgcK
Excited to join @alliance4cehp.bsky.social in celebrating 50 yrs of advancing continuing education, alongside fellow #CME leaders 🔗 bit.ly/45XLgcK
January 23, 2026 at 8:48 PM
We're heading to #Alliance26 to present outcomes from our patient-centered video-first education shaped by partners like @aafanational.bsky.social
Excited to join @alliance4cehp.bsky.social in celebrating 50 yrs of advancing continuing education, alongside fellow #CME leaders 🔗 bit.ly/45XLgcK
Excited to join @alliance4cehp.bsky.social in celebrating 50 yrs of advancing continuing education, alongside fellow #CME leaders 🔗 bit.ly/45XLgcK
📣 We're expanding our Advisory Board! Guidance from #oncologists like Dr. Aaron Lisberg, MD, Dr. Ghassan Abou-Alfa, MD, JD, MBA, PhD(hc), & Dr. Hans Lee, MD ensures our video-first education stays grounded in real-world needs & evolving standards of care. Full press release: prn.to/3ZpaZqO
January 21, 2026 at 3:20 PM
📣 We're expanding our Advisory Board! Guidance from #oncologists like Dr. Aaron Lisberg, MD, Dr. Ghassan Abou-Alfa, MD, JD, MBA, PhD(hc), & Dr. Hans Lee, MD ensures our video-first education stays grounded in real-world needs & evolving standards of care. Full press release: prn.to/3ZpaZqO
Explore expert-led #CME on bullous pemphigoid, featuring new insights into disease biology and treatment.
Now available to watch: 👉 bit.ly/49KgwOA
#MedicalEducation #BullousPemphigoid #Dermatology #AutoimmuneDisease #BiologicTherapies
Now available to watch: 👉 bit.ly/49KgwOA
#MedicalEducation #BullousPemphigoid #Dermatology #AutoimmuneDisease #BiologicTherapies
January 8, 2026 at 9:00 PM
Explore expert-led #CME on bullous pemphigoid, featuring new insights into disease biology and treatment.
Now available to watch: 👉 bit.ly/49KgwOA
#MedicalEducation #BullousPemphigoid #Dermatology #AutoimmuneDisease #BiologicTherapies
Now available to watch: 👉 bit.ly/49KgwOA
#MedicalEducation #BullousPemphigoid #Dermatology #AutoimmuneDisease #BiologicTherapies
📣 Medlive & @nordrare.bsky.social (NORD) have extended our exclusive CME partnership. We are eager to introduce innovative education models, integrate real-world data, and continue to empower the #RareDisease community. Read the full press release here: bit.ly/3YuWGka
January 6, 2026 at 3:30 PM
📣 Medlive & @nordrare.bsky.social (NORD) have extended our exclusive CME partnership. We are eager to introduce innovative education models, integrate real-world data, and continue to empower the #RareDisease community. Read the full press release here: bit.ly/3YuWGka
Early diagnosis matters in C3 glomerulopathy. This #CME activity explores symptom recognition, complement pathways, and emerging therapies.
👉 Watch now: bit.ly/48TbwXO
#MedicalEducation #Nephrology #KidneyDisease #RareDisease #C3G #GlomerularDisease
👉 Watch now: bit.ly/48TbwXO
#MedicalEducation #Nephrology #KidneyDisease #RareDisease #C3G #GlomerularDisease
December 23, 2025 at 9:00 PM
Early diagnosis matters in C3 glomerulopathy. This #CME activity explores symptom recognition, complement pathways, and emerging therapies.
👉 Watch now: bit.ly/48TbwXO
#MedicalEducation #Nephrology #KidneyDisease #RareDisease #C3G #GlomerularDisease
👉 Watch now: bit.ly/48TbwXO
#MedicalEducation #Nephrology #KidneyDisease #RareDisease #C3G #GlomerularDisease
Stay current on diagnosing and treating hypophosphatasia with expert guidance on emerging enzyme therapies and multidisciplinary care.
👉 View the on demand program: bit.ly/4sfJTQq
#CME #HCPEducation #RareDiseaseEducation #Hypophosphatasia #MedicalEducation
👉 View the on demand program: bit.ly/4sfJTQq
#CME #HCPEducation #RareDiseaseEducation #Hypophosphatasia #MedicalEducation
December 22, 2025 at 9:00 PM
Stay current on diagnosing and treating hypophosphatasia with expert guidance on emerging enzyme therapies and multidisciplinary care.
👉 View the on demand program: bit.ly/4sfJTQq
#CME #HCPEducation #RareDiseaseEducation #Hypophosphatasia #MedicalEducation
👉 View the on demand program: bit.ly/4sfJTQq
#CME #HCPEducation #RareDiseaseEducation #Hypophosphatasia #MedicalEducation
Test your knowledge in this interactive #CME for healthcare professionals. 🩺🧠
Explore cardiovascular kidney metabolic syndrome with expert insights and real world cases.
👉 Learn more today: bit.ly/4p2uvEa
#MedicalEducation #Cardiology #Nephrology #Endocrinology
Explore cardiovascular kidney metabolic syndrome with expert insights and real world cases.
👉 Learn more today: bit.ly/4p2uvEa
#MedicalEducation #Cardiology #Nephrology #Endocrinology
December 18, 2025 at 11:30 PM
Test your knowledge in this interactive #CME for healthcare professionals. 🩺🧠
Explore cardiovascular kidney metabolic syndrome with expert insights and real world cases.
👉 Learn more today: bit.ly/4p2uvEa
#MedicalEducation #Cardiology #Nephrology #Endocrinology
Explore cardiovascular kidney metabolic syndrome with expert insights and real world cases.
👉 Learn more today: bit.ly/4p2uvEa
#MedicalEducation #Cardiology #Nephrology #Endocrinology
Boost colorectal cancer screening with evidence based strategies. 🩺 This expert led session covers guideline updates and screening options for diverse patients.
👉 Watch now and earn CME credit: bit.ly/4pJNR20
#MedicalEducation #ColorectalCancer #CancerScreening #PreventiveCare
👉 Watch now and earn CME credit: bit.ly/4pJNR20
#MedicalEducation #ColorectalCancer #CancerScreening #PreventiveCare
December 18, 2025 at 8:00 PM
Boost colorectal cancer screening with evidence based strategies. 🩺 This expert led session covers guideline updates and screening options for diverse patients.
👉 Watch now and earn CME credit: bit.ly/4pJNR20
#MedicalEducation #ColorectalCancer #CancerScreening #PreventiveCare
👉 Watch now and earn CME credit: bit.ly/4pJNR20
#MedicalEducation #ColorectalCancer #CancerScreening #PreventiveCare
Celebrating the gift of collaboration 🎁 We’re proud to highlight Medlive’s 2025 milestone: 85 million patients impacted and counting. A heartfelt thank you to our 175+ organization strong partner network for their continued trust in Medlive to deliver medical education to all.
December 17, 2025 at 3:20 PM
Celebrating the gift of collaboration 🎁 We’re proud to highlight Medlive’s 2025 milestone: 85 million patients impacted and counting. A heartfelt thank you to our 175+ organization strong partner network for their continued trust in Medlive to deliver medical education to all.
New Alzheimer’s treatments are changing care. This #CME covers patient selection, safe initiation, side effect monitoring, and shared decision making with patients and caregivers. 🧠📚
Register now to earn CME credit: bit.ly/4qevGkN
#MedicalEducation #AlzheimersDisease #Neurology #DementiaCare
Register now to earn CME credit: bit.ly/4qevGkN
#MedicalEducation #AlzheimersDisease #Neurology #DementiaCare
December 16, 2025 at 10:00 PM
New Alzheimer’s treatments are changing care. This #CME covers patient selection, safe initiation, side effect monitoring, and shared decision making with patients and caregivers. 🧠📚
Register now to earn CME credit: bit.ly/4qevGkN
#MedicalEducation #AlzheimersDisease #Neurology #DementiaCare
Register now to earn CME credit: bit.ly/4qevGkN
#MedicalEducation #AlzheimersDisease #Neurology #DementiaCare
Learn how PTEN deficiency impacts prognosis and treatment selection, with practical insights on testing and emerging PI3K/AKT-targeted approaches.
👉 Access the program now. bit.ly/49dqZln
#HCPEducation #mHSPC #ProstateCancer #Oncology #Urology
👉 Access the program now. bit.ly/49dqZln
#HCPEducation #mHSPC #ProstateCancer #Oncology #Urology
December 16, 2025 at 8:20 PM
Learn how PTEN deficiency impacts prognosis and treatment selection, with practical insights on testing and emerging PI3K/AKT-targeted approaches.
👉 Access the program now. bit.ly/49dqZln
#HCPEducation #mHSPC #ProstateCancer #Oncology #Urology
👉 Access the program now. bit.ly/49dqZln
#HCPEducation #mHSPC #ProstateCancer #Oncology #Urology
What a week at #SABCS25! Grateful to share results from initiatives, developed in partnership with Living Beyond Breast Cancer, Surviving Breast Cancer, & Salud America. We spotlighted toxicity management, #HER2-aligned decisions & equity in #TNBC for Hispanic/Latina communities. 🔗 bit.ly/3KNajrO
December 15, 2025 at 8:59 PM
What a week at #SABCS25! Grateful to share results from initiatives, developed in partnership with Living Beyond Breast Cancer, Surviving Breast Cancer, & Salud America. We spotlighted toxicity management, #HER2-aligned decisions & equity in #TNBC for Hispanic/Latina communities. 🔗 bit.ly/3KNajrO
New therapies, updated @kdigo.org guidance, and fresh insight into #IgAN are reshaping care.
Watch this expert program on demand anytime for practical guidance that supports stronger diagnosis and treatment. ▶️ bit.ly/4iRPqrX
Watch this expert program on demand anytime for practical guidance that supports stronger diagnosis and treatment. ▶️ bit.ly/4iRPqrX
December 11, 2025 at 9:00 PM
New therapies, updated @kdigo.org guidance, and fresh insight into #IgAN are reshaping care.
Watch this expert program on demand anytime for practical guidance that supports stronger diagnosis and treatment. ▶️ bit.ly/4iRPqrX
Watch this expert program on demand anytime for practical guidance that supports stronger diagnosis and treatment. ▶️ bit.ly/4iRPqrX
Our new on demand program breaks down how new FDA approved subcutaneous infusion therapies and emerging options are changing Parkinson’s care.
Hear practical insights and caregiver perspectives from leading experts 👉 bit.ly/4psMVPf
Hear practical insights and caregiver perspectives from leading experts 👉 bit.ly/4psMVPf
December 10, 2025 at 8:00 PM
Our new on demand program breaks down how new FDA approved subcutaneous infusion therapies and emerging options are changing Parkinson’s care.
Hear practical insights and caregiver perspectives from leading experts 👉 bit.ly/4psMVPf
Hear practical insights and caregiver perspectives from leading experts 👉 bit.ly/4psMVPf
📣 We'll be at #SABCS25 presenting topics in #BreastCancer care:
Managing complex toxicities 👉 12/10 from 12:30–2:30 PM
Advancing equity for #TNBC 👉 12/10 from 5–6:30 PM
HER2 expression 👉 12/12 from 12:30–2 PM
🔗 bit.ly/3XNtrJ0
👥 Surviving Breast Cancer, Salud America, Living Beyond Breast Cancer
Managing complex toxicities 👉 12/10 from 12:30–2:30 PM
Advancing equity for #TNBC 👉 12/10 from 5–6:30 PM
HER2 expression 👉 12/12 from 12:30–2 PM
🔗 bit.ly/3XNtrJ0
👥 Surviving Breast Cancer, Salud America, Living Beyond Breast Cancer
December 9, 2025 at 7:58 PM
📣 We'll be at #SABCS25 presenting topics in #BreastCancer care:
Managing complex toxicities 👉 12/10 from 12:30–2:30 PM
Advancing equity for #TNBC 👉 12/10 from 5–6:30 PM
HER2 expression 👉 12/12 from 12:30–2 PM
🔗 bit.ly/3XNtrJ0
👥 Surviving Breast Cancer, Salud America, Living Beyond Breast Cancer
Managing complex toxicities 👉 12/10 from 12:30–2:30 PM
Advancing equity for #TNBC 👉 12/10 from 5–6:30 PM
HER2 expression 👉 12/12 from 12:30–2 PM
🔗 bit.ly/3XNtrJ0
👥 Surviving Breast Cancer, Salud America, Living Beyond Breast Cancer
Our new program on emerging therapies for SLE and lupus nephritis goes live at 1pm ET!
Don't miss it 👉 bit.ly/48vj0i3
Don't miss it 👉 bit.ly/48vj0i3
December 9, 2025 at 4:00 PM
Our new program on emerging therapies for SLE and lupus nephritis goes live at 1pm ET!
Don't miss it 👉 bit.ly/48vj0i3
Don't miss it 👉 bit.ly/48vj0i3
The RRMM landscape is shifting as earlier CAR T-cell therapy moves into focus 🔍
Watch our new on demand video for data, candidate selection, collaboration tips and guidance for managing CRS and ICANS 🎥
👉 Watch it now: bit.ly/4ijzdvr
#MultipleMyeloma #CART #Oncology
Watch our new on demand video for data, candidate selection, collaboration tips and guidance for managing CRS and ICANS 🎥
👉 Watch it now: bit.ly/4ijzdvr
#MultipleMyeloma #CART #Oncology
December 8, 2025 at 9:19 PM
The RRMM landscape is shifting as earlier CAR T-cell therapy moves into focus 🔍
Watch our new on demand video for data, candidate selection, collaboration tips and guidance for managing CRS and ICANS 🎥
👉 Watch it now: bit.ly/4ijzdvr
#MultipleMyeloma #CART #Oncology
Watch our new on demand video for data, candidate selection, collaboration tips and guidance for managing CRS and ICANS 🎥
👉 Watch it now: bit.ly/4ijzdvr
#MultipleMyeloma #CART #Oncology
Catch our poster session at #ASH25 on 12/6 from 5:30-7:30 PM where we’ll share how, with Blood Cancer United, we've generated insights on bringing #BiospecificAntibody considerations into real-world community practice for #MultipleMyeloma patients.🩸♥️ Learn more: 🔗 bit.ly/4rEYFQe
@ash.hematology.org
@ash.hematology.org
December 6, 2025 at 2:00 PM
Catch our poster session at #ASH25 on 12/6 from 5:30-7:30 PM where we’ll share how, with Blood Cancer United, we've generated insights on bringing #BiospecificAntibody considerations into real-world community practice for #MultipleMyeloma patients.🩸♥️ Learn more: 🔗 bit.ly/4rEYFQe
@ash.hematology.org
@ash.hematology.org
Stay current on the latest in food allergy care. Join us today at 2pm ET to explore new FDA approved treatments, updated care guidelines, and real patient cases. Save your spot 👉 bit.ly/4ponlLu
#FoodAllergy #AllergyCare #CME #PatientSafety
#FoodAllergy #AllergyCare #CME #PatientSafety
December 4, 2025 at 4:00 PM
Stay current on the latest in food allergy care. Join us today at 2pm ET to explore new FDA approved treatments, updated care guidelines, and real patient cases. Save your spot 👉 bit.ly/4ponlLu
#FoodAllergy #AllergyCare #CME #PatientSafety
#FoodAllergy #AllergyCare #CME #PatientSafety